This website is intended for healthcare professionals



Following the announcement of serious shortage protocols (SSPs) on Thursday, December 15, five new SSPs have been issued..

Drug Breakdown: Celecoxib

Day 1: The discovery of the COX-2 channel in the early 1990s led to two new NSAIDs designed and licensed with COX-2 selective action. The new drug target implied therapeutic and adverse drug effect...


The batches shown in Table 1 of Targocid 200 mg powder for injection/infusion or oral solution are being recalled immediately by Sanofi UK. This is due to out of specification results for bacterial...


Following the publication of final draught National Institute for Health and Care Excellence (NICE) guidance on 23 September 2022, approximately 1500 people aged 12 years and older with melanoma are...

Drug Breakdown: sildenafil (Viagra)

With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate .

Drug updates: August

Following a deal with the manufacturer of Dexcom One, patients with type 1 diabetes in England are now eligible for continuous glucose monitors (CGMs). Until recently, the only CGMs widely available...


The National Institute of Health and Care Excellence (NICE) has published final draft guidance recommending icosapent ethyl to reduce the risk of cardiovascular events such as heart attacks and...

Drug Breakdown: Omalizumab

Dr Sharon Rees @reesprescribe.

Prescribing updates: July

The UK government has published a new drug safety update on the use of metformin and its effects on a patient's vitamin B12 levels..


Following the National Institute of Health and Care Excellence's (NICE) recommendation of relugolix with estradiol and norethisterone acetate in final draft guidance, around 4500 women with uterine...


The National Institute of Health and Care Excellence (NICE) has recommended an innovative and potentially life-extending drug for treating people with a specific gene mutation of advanced...


The Medicines and Healthcare products Regulatory Agency (MHRA) has approved tixagevimab/cilgavimab (Evusheld), a new monoclonal antibody combination, for COVID-19 pre-exposure prophylaxis, or...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP